Literature DB >> 18441279

Isoprostanes and lung vascular pathology.

Luke J Janssen1.   

Abstract

Isoprostanes are products of peroxidative attack of membrane lipids. As such, they accumulate to substantial levels in conditions of oxidative stress, including many pulmonary vascular diseases such as acute lung injury and pulmonary hypertension, and are increasingly being used as indicators of disease state and severity. However, our group and others have hypothesized that they are more than inert markers, but may also act as signal transduction molecules. As isomers of prostaglandins, they can exert powerful biological effects on many lung cell types through actions on prostanoid receptors. In this review, we collect many lines of evidence that point to causal roles for the isoprostanes in those disease states.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18441279     DOI: 10.1165/rcmb.2008-0109TR

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  16 in total

Review 1.  Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension.

Authors:  Marjorie Barrier; Jolyane Meloche; Maria Helena Jacob; Audrey Courboulin; Steeve Provencher; Sébastien Bonnet
Journal:  Cell Mol Life Sci       Date:  2012-03-25       Impact factor: 9.261

2.  Reactive Oxygen Species, Biomarkers of Microvascular Maturation and Alveolarization, and Antioxidants in Oxidative Lung Injury.

Authors:  Arwin M Valencia; Maria A Abrantes; Jamal Hasan; Jacob V Aranda; Kay D Beharry
Journal:  React Oxyg Species (Apex)       Date:  2018-11

3.  Hemoglobin attenuates the effects of inspired oxygen on plasma isofurans in humans during upper-limb surgery.

Authors:  Tomas B Corcoran; Anne E Barden; Emilie Mas; Sina Grape; Viktoria Koren; Michael Phillips; L Jackson Roberts; Trevor A Mori
Journal:  Free Radic Biol Med       Date:  2011-06-27       Impact factor: 7.376

4.  Biosynthesis of oxidized lipid mediators via lipoprotein-associated phospholipase A2 hydrolysis of extracellular cardiolipin induces endothelial toxicity.

Authors:  Justin R Buland; Karla J Wasserloos; Vladimir A Tyurin; Yulia Y Tyurina; Andrew A Amoscato; Rama K Mallampalli; Bill B Chen; Jing Zhao; Yutong Zhao; Solomon Ofori-Acquah; Valerian E Kagan; Bruce R Pitt
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-05-27       Impact factor: 5.464

Review 5.  The isoprostanes--25 years later.

Authors:  Ginger L Milne; Qi Dai; L Jackson Roberts
Journal:  Biochim Biophys Acta       Date:  2014-10-30

Review 6.  Isoprostanes and asthma.

Authors:  Judith A Voynow; Apparao Kummarapurugu
Journal:  Biochim Biophys Acta       Date:  2011-05-08

Review 7.  Markers of oxidant stress that are clinically relevant in aging and age-related disease.

Authors:  Kimberly D Jacob; Nicole Noren Hooten; Andrzej R Trzeciak; Michele K Evans
Journal:  Mech Ageing Dev       Date:  2013-02-18       Impact factor: 5.432

Review 8.  Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension.

Authors:  Patrick Crosswhite; Zhongjie Sun
Journal:  J Hypertens       Date:  2010-02       Impact factor: 4.844

9.  Akt-mediated transactivation of the S1P1 receptor in caveolin-enriched microdomains regulates endothelial barrier enhancement by oxidized phospholipids.

Authors:  Patrick A Singleton; Santipongse Chatchavalvanich; Panfeng Fu; Junjie Xing; Anna A Birukova; Jennifer A Fortune; Alexander M Klibanov; Joe G N Garcia; Konstantin G Birukov
Journal:  Circ Res       Date:  2009-03-12       Impact factor: 17.367

Review 10.  Role of oxidized lipids in pulmonary arterial hypertension.

Authors:  Salil Sharma; Grégoire Ruffenach; Soban Umar; Negar Motayagheni; Srinivasa T Reddy; Mansoureh Eghbali
Journal:  Pulm Circ       Date:  2016-09       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.